wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34134390-C1AEC4C3-9B77-4B9D-A2EF-EEBF4B702A82
Q34134390-C1AEC4C3-9B77-4B9D-A2EF-EEBF4B702A82
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34134390-C1AEC4C3-9B77-4B9D-A2EF-EEBF4B702A82
Metabolism considerations for kinase inhibitors in cancer treatment
P2860
Q34134390-C1AEC4C3-9B77-4B9D-A2EF-EEBF4B702A82
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34134390-C1AEC4C3-9B77-4B9D-A2EF-EEBF4B702A82
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
81c20bcc5380e0048836ff637165fe9c59fdbb38
P2860
Metabolism and disposition of dasatinib after oral administration to humans.